Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc.

VRDN
Viridian Therapeutics, Inc.US flagNASDAQ Capital Market
19.18
USD
+0.62
- -
1.73BMarket Cap

Viridian Therapeutics, Inc. (VRDN) Stock Split History

Learn about Viridian Therapeutics, Inc.'s most recent 1-for-15 basis stock split on November 13, 2020. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Viridian Therapeutics, Inc.'s most recent stock split

Split Date: 2020-11-13
Split Ratio: 1:15
Price Before Split: $1.05
Price After Split: $0.07

Developer API

Get VRDN split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/VRDN

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 15.00 times fewer shares (a 1:15 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Viridian Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2020-11-131:15Yes$1.05$0.07
2016-11-071:15Yes$0.20$0.01

About Viridian Therapeutics, Inc.

Company overview and industry information

Viridian Therapeutics, Inc. (VRDN) operates in the Biotechnology industry. The recent 1-for-15 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Viridian Therapeutics, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.